GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (XTER:FRE) » Definitions » Cyclically Adjusted PS Ratio

Fresenius SE KGaA (XTER:FRE) Cyclically Adjusted PS Ratio : 0.42 (As of May. 21, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Fresenius SE KGaA Cyclically Adjusted PS Ratio?

As of today (2024-05-21), Fresenius SE KGaA's current share price is €27.75. Fresenius SE KGaA's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was €66.83. Fresenius SE KGaA's Cyclically Adjusted PS Ratio for today is 0.42.

The historical rank and industry rank for Fresenius SE KGaA's Cyclically Adjusted PS Ratio or its related term are showing as below:

XTER:FRE' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.32   Med: 0.72   Max: 1.59
Current: 0.42

During the past years, Fresenius SE KGaA's highest Cyclically Adjusted PS Ratio was 1.59. The lowest was 0.32. And the median was 0.72.

XTER:FRE's Cyclically Adjusted PS Ratio is ranked better than
76.7% of 339 companies
in the Healthcare Providers & Services industry
Industry Median: 1.21 vs XTER:FRE: 0.42

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Fresenius SE KGaA's adjusted revenue per share data for the three months ended in Dec. 2023 was €10.081. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €66.83 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Fresenius SE KGaA Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Fresenius SE KGaA's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Cyclically Adjusted PS Ratio Chart

Fresenius SE KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.01 0.72 0.61 0.41 0.42

Fresenius SE KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.38 0.38 0.44 0.42

Competitive Comparison of Fresenius SE KGaA's Cyclically Adjusted PS Ratio

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Cyclically Adjusted PS Ratio falls into.



Fresenius SE KGaA Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Fresenius SE KGaA's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=27.75/66.83
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius SE KGaA's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Fresenius SE KGaA's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=10.081/123.7729*123.7729
=10.081

Current CPI (Dec. 2023) = 123.7729.

Fresenius SE KGaA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 9.556 99.543 11.882
201406 10.020 99.543 12.459
201409 11.026 99.823 13.671
201412 11.936 99.543 14.841
201503 11.831 99.717 14.685
201506 12.587 100.417 15.515
201509 12.613 100.417 15.547
201512 13.198 99.717 16.382
201603 12.730 100.017 15.754
201606 13.124 100.717 16.128
201609 13.402 101.017 16.421
201612 14.180 101.217 17.340
201703 14.962 101.417 18.260
201706 15.329 102.117 18.580
201709 14.849 102.717 17.893
201712 15.567 102.617 18.776
201803 14.542 102.917 17.489
201806 15.014 104.017 17.866
201809 14.637 104.718 17.300
201812 15.825 104.217 18.794
201903 15.216 104.217 18.071
201906 15.782 105.718 18.477
201909 15.704 106.018 18.334
201912 16.663 105.818 19.490
202003 16.359 105.718 19.153
202006 16.031 106.618 18.610
202009 15.968 105.818 18.677
202012 16.656 105.518 19.538
202103 16.081 107.518 18.512
202106 16.577 108.486 18.913
202109 16.706 109.435 18.895
202112 17.845 110.384 20.010
202203 17.404 113.968 18.901
202206 17.787 115.760 19.018
202209 9.564 118.818 9.963
202212 10.067 119.345 10.441
202303 18.154 122.402 18.357
202306 19.423 123.140 19.523
202309 9.786 124.195 9.753
202312 10.081 123.773 10.081

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Fresenius SE KGaA  (XTER:FRE) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Fresenius SE KGaA Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius SE KGaA (XTER:FRE) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
Executives
Dr. Michael Moser Board of Directors
Sara Hennicken Board of Directors
Michael Sen Board of Directors
Dr. Francesco De Meo Board of Directors
Stephan Sturm Board of Directors
Wolfgang Kirsch Supervisory Board
Mats Henriksson Board of Directors
Dr. Gerd Krick Supervisory Board

Fresenius SE KGaA (XTER:FRE) Headlines

No Headlines